参考文献/References:
[1]Adany R,Piko P,Fiatal S,et al.Prevalence of Insulin Resistance in the Hungarian General and Roma Populations as Defined by Using Data Generated in a Complex Health (Interview and Examination) Survey[J].Int J Environ Res Public Health,2020,17(13):354-359.[2]Zhang M,Liu D,Qin P,et al.Association of metabolic score for insulin resistance and its 6-year change with incident type 2 diabetes mellitus[J].J Diabetes,2021,13(9):725-734.[3]Moghetti P.Insulin Resistance and Polycystic Ovary Syndrome[J].Curr Pharm Des,2016,22(36):5526-5534.[4]Rinaldi L,Pafundi PC,Galiero R,et al.Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review[J].Antioxidants (Basel),2021,10(2):413.[5]Femminella GD,Livingston NR,Raza S,et al.Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer’s subjects?[J].Alzheimers Res Ther,2021,13(1):47.[6]Tyagi A,Pugazhenthi S.Targeting Insulin Resistance to Treat Cognitive Dysfunction[J].Mol Neurobiol,2021,58(6):2672-2691.[7]Izquierdo AG,Crujeiras AB.Role of epigenomic mechanisms in the onset and management of insulin resistance[J].Rev Endocr Metab Disord,2019,20(1):89-102.[8]Onyango AN.Cellular Stresses and Stress Responses in the Pathogenesis of Insulin Resistance[J].Oxid Med Cell Longev,2018,2018:4321714.[9]刘树林.卫郁营涩与胰岛素抵抗相关性探讨与研究[D].广州:广州中医药大学,2007.[10]黄洪,田成功.胰岛素临床应用与胰岛素抵抗及其临床处理[J].实用糖尿病杂志,2014,10(3):8-9.[11]Li S,Zhang B.Traditional Chinese medicine network pharmacology: theory, methodology and application[J].Chin J Nat Med,2013,11(2):110-120.[12]刘洪兴.基于数据挖掘的仝小林教授辨治胰岛素抵抗经验初探[D].北京:北京中医药大学,2014.[13]吴勉华,过伟峰,周学平,等.研究周仲瑛“瘀热”学说的思路与方法[J].中华中医药杂志,2009,24(10):1319-1321.[14]倪慧明,董哲毅,陈香美.黄芪主要活性成分对糖尿病肾病的疗效机制研究进展[J].解放军医学杂志,2021,46(3):294-299.[15]陈丽叶,常希光,冯晓光,等.山药多糖的体外抗氧化活性[J].食品科学,2021,42(19):122-128.[16]王妙然,李秋艳,马学竹,等.基于网络药理学的复方丹参滴丸治疗糖尿病视网膜病变的作用机制研究[J].中国中医眼科杂志,2020,30(4):293-302.[17]Perez-Torres I,Castrejon-Tellez V,Soto M E,et al.Oxidative Stress, Plant Natural Antioxidants, and Obesity[J].Int J Mol Sci,2021,22(4):1786.[18]Peng J,Li Q,Li K,et al.Quercetin Improves Glucose and Lipid Metabolism of Diabetic Rats: Involvement of Akt Signaling and SIRT1[J].J Diabetes Res,2017,2017:3417306.[19]Wang S,Wuniqiemu T,Tang W,et al.Luteolin inhibits autophagy in allergic asthma by activating PI3K/Akt/mTOR signaling and inhibiting Beclin-1-PI3KC3 complex[J].Int Immunopharmacol,2021,94:107460.[20]Zhang KK,Wang H,Qu D,et al.Luteolin Alleviates Methamphetamine-Induced Hepatotoxicity by Suppressing the p53 Pathway-Mediated Apoptosis, Autophagy, and Inflammation in Rats[J].Front Pharmacol,2021,12:641917.[21]Dar AA,Fehaid A,Alkhatani S,et al.The protective role of luteolin against the methotrexate-induced hepato-renal toxicity via its antioxidative, anti-inflammatory, and anti-apoptotic effects in rats[J].Hum Exp Toxicol,2021,40(7):1194-1207.[22]Zhou YP,Li GC.Kaempferol Protects Cell Damage in In Vitro Ischemia Reperfusion Model in Rat Neuronal PC12 Cells[J].Biomed Res Int,2020,2020:2461079.[23]Kitakaze T,Makiyama A,Nakai R,et al.Kaempferol modulates TCDD- and t-BHQ-induced drug-metabolizing enzymes and luteolin enhances this effect[J].Food Funct,2020,11(4):3668-3680.[24]Petrenko O,Li J,Cimica V,et al.IL-6 promotes MYC-induced B cell lymphomagenesis independent of STAT3[J].PLoS One,2021,16(3):e247394.[25]Priceman SJ,Kujawski M,Shen S,et al.Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance[J].Proc Natl Acad Sci U S A,2013,110(32):13079-13084.[26]Li H,Lee J,He C,et al.Suppression of the mTORC1/STAT3/Notch1 pathway by activated AMPK prevents hepatic insulin resistance induced by excess amino acids[J].Am J Physiol Endocrinol Metab,2014,306(2):E197-E209.[27]Granato M,Rizzello C,Gilardini MM,et al.Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways[J].J Nutr Biochem,2017,41:124-136.[28]Júlio de Souza AL,Beatriz Mahler Pereira A,Robison de Oliveira J,et al.Dermatophagoides pteronyssinus-induced pro-inflammatory responses mediated via STAT3 and NF-kappaB signaling pathways in human bronchial epithelial cells - Inhibitory effects of Lafoensia pacari and ellagic acid[J].J Pharmacol Sci,2020,142(4):157-164.[29]Lu N,Malemud CJ.Extracellular Signal-Regulated Kinase: A Regulator of Cell Growth, Inflammation, Chondrocyte and Bone Cell Receptor-Mediated Gene Expression[J].Int J Mol Sci,2019,20(15):3792.[30]Nandipati KC,Subramanian S,Agrawal DK.Protein kinases: mechanisms and downstream targets in inflammation-mediated obesity and insulin resistance[J].Mol Cell Biochem,2017,426(1-2):27-45.[31]Huang XF,Zhang JL,Huang DP,et al.A network pharmacology strategy to investigate the anti-inflammatory mechanism of luteolin combined with in vitro transcriptomics and proteomics[J].Int Immunopharmacol,2020,86:106727.[32]Kim E,Ahuja A,Kim MY,et al.DNA or Protein Methylation-Dependent Regulation of Activator Protein-1 Function[J].Cells,2021,10(2):461.[33]Lee YJ,Beak SY,Choi I,et al.Quercetin and its metabolites protect hepatocytes against ethanol-induced oxidative stress by activation of Nrf2 and AP-1[J].Food Sci Biotechnol,2018,27(3):809-817.[34]Higa JK,Panee J.Bamboo extract reduces interleukin 6 (IL-6) overproduction under lipotoxic conditions through inhibiting the activation of NF-kappaB and AP-1 pathways[J].Cytokine,2011,55(1):18-23.[35]Strycharz J,Drzewoski J,Szemraj J,et al.Is p53 Involved in Tissue-Specific Insulin Resistance Formation?[J].Oxid Med Cell Longev,2017,2017:9270549.
相似文献/References:
[1]吕 宁,徐 昕,黄 永,等.公安民警皮肤软纤维瘤与代谢综合征危险因素相关性研究[J].医学信息,2018,31(10):69.[doi:10.3969/j.issn.1006-1959.2018.10.021]
LV Ning,XU Xin,HUANG Yong,et al.Correlative Study on Skin Soft Fibroma and Risk Factors of Metabolic Syndrome in Public Security Police[J].Journal of Medical Information,2018,31(20):69.[doi:10.3969/j.issn.1006-1959.2018.10.021]
[2]杨锦龙,刘 欢,吕秋菊,等.非糖尿病患者糖化血红蛋白和胰岛素抵抗与
冠状动脉病变程度的相关性研究[J].医学信息,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
YANG Jin-long,LIU Huan,LV Qiu-ju,et al.Correlation between Glycosylated Hemoglobin and Insulin Resistance and Severity of Coronary Artery Disease in Non-diabetic Patients[J].Journal of Medical Information,2018,31(20):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
[3]崔姗姗,刘 英,江 霞.非酒精性脂肪性肝病与胰岛素抵抗的研究进展[J].医学信息,2022,35(10):66.[doi:10.3969/j.issn.1006-1959.2022.10.016]
CUI Shan-shan,LIU Ying,JIANG Xia.Research Progress on Non-alcoholic Fatty Liver Disease and Insulin Resistance[J].Journal of Medical Information,2022,35(20):66.[doi:10.3969/j.issn.1006-1959.2022.10.016]
[4]何 丽.应激性高血糖与急性心肌梗死的机制研究[J].医学信息,2022,35(10):74.[doi:10.3969/j.issn.1006-1959.2022.10.018]
HE Li.Mechanism of Stress Hyperglycemia and Acute Myocardial Infarction[J].Journal of Medical Information,2022,35(20):74.[doi:10.3969/j.issn.1006-1959.2022.10.018]
[5]陈 丽,郝丽娟.多囊卵巢综合征患者腹型肥胖、高雄、胰岛素抵抗及脂代谢的相关性分析[J].医学信息,2022,35(12):113.[doi:10.3969/j.issn.1006-1959.2022.12.027]
CHEN Li,HAO Li-juan.Correlation of Abdominal Obesity, Hyperandrogenism, Insulin Resistance and Lipid Metabolism in Patients with Polycystic Ovary Syndrome[J].Journal of Medical Information,2022,35(20):113.[doi:10.3969/j.issn.1006-1959.2022.12.027]
[6]谢小莉,李 燕,霍 敏,等.老年2型糖尿病患者轻度认知功能障碍与胰岛素抵抗、
白介素-6的相关性研究[J].医学信息,2019,32(15):97.[doi:10.3969/j.issn.1006-1959.2019.15.030]
XIE Xiao-li,LI Yan,HUO Min,et al.Correlation between Mild Cognitive Impairment and Insulin Resistance and
Interleukin-6 in Elderly Type 2 Diabetic Patients[J].Journal of Medical Information,2019,32(20):97.[doi:10.3969/j.issn.1006-1959.2019.15.030]
[7]王本泉,项本宏,邱 钧.胰岛素抵抗与甲状腺结节的关系研究进展[J].医学信息,2022,35(14):154.[doi:10.3969/j.issn.1006-1959.2022.14.040]
WANG Ben-quan,XIANG Ben-hong,QIU Jun.Research Progress on the Relationship Between Insulin Resistance and Thyroid Nodules[J].Journal of Medical Information,2022,35(20):154.[doi:10.3969/j.issn.1006-1959.2022.14.040]
[8]刘柏基,熊波波.代谢综合征与良性前列腺增生合并下尿路症状的关系
及治疗研究[J].医学信息,2019,32(17):28.[doi:10.3969/j.issn.1006-1959.2019.17.010]
LIU Bai-ji,XIONG Bo-bo.Relationship between Metabolic Syndrome and Benign Prostatic Hyperplasia with
Lower Urinary Tract Symptoms and Treatment[J].Journal of Medical Information,2019,32(20):28.[doi:10.3969/j.issn.1006-1959.2019.17.010]
[9]赵 猛,孙 娟,褚 璇.苯扎贝特改善2型糖尿病合并高甘油三酯血症患者
胰岛素抵抗的临床分析[J].医学信息,2019,32(17):145.[doi:10.3969/j.issn.1006-1959.2019.17.048]
ZHAO Meng,SUN Juan,CHU Xuan.Clinical Analysis of Bezafibrate in Improving Insulin Resistance in Patients with
Type 2 Diabetes Mellitus Complicated with Hypertriglyceridemia[J].Journal of Medical Information,2019,32(20):145.[doi:10.3969/j.issn.1006-1959.2019.17.048]
[10]陈 越,彭 莉.黄芪对细胞毒素相关蛋白A诱导的大鼠系膜细胞外基质分泌的影响[J].医学信息,2022,35(15):104.[doi:10.3969/j.issn.1006-1959.2022.15.023]
CHEN Yue,PENG Li.Effect of Astragalus Membranaceus on CagA-induced Extracellular Matrix Secretion of Rat Mesangial Cells[J].Journal of Medical Information,2022,35(20):104.[doi:10.3969/j.issn.1006-1959.2022.15.023]